FMR LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43,871,444
-50.0%
8,262,042
-10.3%
0.00%
-42.9%
Q2 2023$87,797,848
-56.4%
9,212,786
-49.7%
0.01%
-22.2%
Q1 2023$201,573,460
+49.0%
18,324,860
+100.5%
0.01%
-30.8%
Q4 2022$135,259,760
-20.7%
9,139,173
+2.4%
0.01%
-27.8%
Q3 2022$170,637,000
+3.8%
8,929,231
+15.8%
0.02%
+12.5%
Q2 2022$164,357,000
+12.9%
7,712,680
+2.1%
0.02%
+33.3%
Q1 2022$145,558,000
-7.0%
7,557,593
+0.2%
0.01%0.0%
Q4 2021$156,467,000
-13.1%
7,544,212
+0.1%
0.01%
-14.3%
Q3 2021$180,041,000
-12.4%
7,536,265
+0.1%
0.01%
-12.5%
Q2 2021$205,514,000
-7.0%
7,530,740
-1.4%
0.02%
-15.8%
Q1 2021$220,922,000
+20.0%
7,636,449
+16.7%
0.02%
+18.8%
Q4 2020$184,116,000
+9.7%
6,545,164
+14.3%
0.02%
-5.9%
Q3 2020$167,842,000
-3.0%
5,728,393
+0.1%
0.02%
-10.5%
Q2 2020$173,069,000
+1.7%
5,723,182
+0.2%
0.02%
-20.8%
Q1 2020$170,258,0005,713,3430.02%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$165,956,00012.78%
Bain Capital Life Sciences Investors, LLC 3,000,000$57,330,0006.84%
Pivotal bioVenture Partners Investment Advisor LLC 569,041$10,874,0003.97%
Logos Global Management LP 1,525,000$29,143,0003.58%
1492 Capital Management LLC 178,320$3,408,0002.45%
Cormorant Asset Management, LP 1,000,000$19,110,0001.34%
MPM BioImpact LLC 257,185$4,915,0001.16%
Orbimed Advisors 2,800,000$53,508,0000.99%
SECTORAL ASSET MANAGEMENT INC 220,985$4,223,0000.83%
Rubric Capital Management LP 472,047$9,021,0000.45%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders